Oligodendrocyte injury is an early event in lesions of multiple sclerosis.
about
A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 casesDistinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesisMultiple functions of the myelin-associated glycoprotein MAG (siglec-4a) in formation and maintenance of myelinCorrelations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis.p53 and the CNS: tumors and developmental abnormalities.Multiphasic disseminated encephalomyelitis presenting as alternating hemiplegia.A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosisImportance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.Glial cells as targets for cytotoxic immune mediators.Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability.The diagnosis and management of multiple sclerosis.Phosphodiesterase-Ialpha/autotaxin (PD-Ialpha/ATX): a multifunctional protein involved in central nervous system development and disease.p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cellsThe epidemiology of multiple sclerosis: a general overview.Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis.Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease.Oligodendrocytes and the early multiple sclerosis lesion.Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis.Timing of Future Remyelination Therapies and Their Potential to Stop Multiple Sclerosis Progression.Structural dynamics of oligodendrocyte lysis by perforin in culture: relevance to multiple sclerosis.CD4 T-cell epitopes of human alpha B-crystallin.Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta.Spontaneous and induced remyelination in multiple sclerosis and the Theiler's virus model of central nervous system demyelination.Inflammation in EAE: role of chemokine/cytokine expression by resident and infiltrating cells.Distinct age and differentiation-state dependent metabolic profiles of oligodendrocytes under optimal and stress conditionsThe reactions of the oligodendrocyte.Promotion of endogenous remyelination in multiple sclerosis.Growth factors and myelin regeneration in multiple sclerosis.Molecular changes in white matter adjacent to an active demyelinating lesion in early multiple sclerosis.NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.Sublethal oligodendrocyte injury: A reversible condition in multiple sclerosis?Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis.Identification of glial cell proliferation in early multiple sclerosis lesions.Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis.Nerve growth factor signal transduction in mature pig oligodendrocytes.Synchrotron X-ray fluorescence reveals abnormal metal distributions in brain and spinal cord in spinocerebellar ataxia: a case report.Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study.
P2860
Q28139227-EE46F853-032D-413D-A91E-81538EDD2344Q28293364-21AEBA63-7CB9-4D5B-895C-6CDB44F7EF9FQ28588494-DA03B7C3-11B9-48B9-AE4E-F6EDDB0B0905Q32091527-9733BA4E-AA8C-4A75-AC62-A703DBF20799Q33211732-36306273-CACA-4541-8433-A3213BCE4639Q33596386-9C5D4786-6E79-46E4-975B-DBB2C44CC437Q33596429-34F73EDC-FB0C-485E-87AA-012FD2B82D83Q33632282-C4B32CCD-980F-4EAF-93B2-5D130F8A6319Q33733986-070894AE-8279-4B2C-B370-B556671AC825Q33735120-ECEBDAB9-70B5-47B1-A3EB-0C902E36175DQ33740931-7B47AA96-8D7F-4968-BD34-62809DDC8123Q34398657-A4B3DA0F-BF18-4F0E-AB7A-1066242D1CD6Q34737619-FC404550-8536-46C5-90E0-92B5389BD78BQ36228017-DF88B425-C30A-485A-9BCE-ED637B22CD3DQ36305556-32877D1E-00BA-48C1-93DE-1446D4C7864CQ36562423-E9EE52BB-477B-4E9F-980E-337F4D03DAE0Q36730661-5D1BBD5D-7409-45D6-9226-C4E6F1776D8CQ36771875-D9F36E95-D839-4567-AA04-F772AD3620DEQ36885953-8A8333CF-9312-48F1-85D1-0C4C93DC67CBQ38029278-BF2A9CE0-8C8C-4170-815B-3B43F909FD58Q38040792-A8025447-897C-43D2-9758-3C870E2C6FDDQ38769752-37A0A6B8-4443-43BB-B13D-54C7B8480415Q39566423-EB748AB1-E960-4115-BBD0-7764EAEDA3F6Q40595651-169EDE20-10BD-407A-97E9-187C57D59C07Q40667947-194D5C9C-E522-41D4-90AF-E0C4F07BD1FEQ40926628-67E478DC-2A0A-4356-951F-7AF9E8A7A42EQ40944429-E6C3B30A-27D2-4F6A-8AA9-123CF57B3886Q41323457-398D1131-97F9-4396-B945-6E676B685F0FQ41363892-033953BA-B980-4AD4-B355-75E0DA9D34DEQ41589680-155B800B-E6C5-4F56-85E4-21B3588E3270Q41589718-D176159C-D0BD-4B09-8ABF-BC5568D11F00Q46240184-992C4462-3C9D-4309-A180-64F4DB7F9E9EQ46863661-20371199-4C96-40B7-AE50-CAE80A8644AAQ47902360-7A3871B6-4967-41B6-AB46-B62ACD85831EQ48048028-8DFBB8B4-7EDE-4BF7-AF67-C8312885D170Q48375316-FFB0B3C6-0FB2-4BF6-A183-E3121EEF957DQ48550799-17108F93-533C-4EE5-AE07-E44B321C33A2Q48569905-C7101108-D04F-43BB-BB75-F5DF58BC711BQ48691950-F2D3AA3C-45BC-46A5-8C40-6745A6791A8AQ50202910-1B636EAB-B9F1-4927-8113-4AE2966D369B
P2860
Oligodendrocyte injury is an early event in lesions of multiple sclerosis.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Oligodendrocyte injury is an early event in lesions of multiple sclerosis.
@en
Oligodendrocyte injury is an early event in lesions of multiple sclerosis.
@nl
type
label
Oligodendrocyte injury is an early event in lesions of multiple sclerosis.
@en
Oligodendrocyte injury is an early event in lesions of multiple sclerosis.
@nl
prefLabel
Oligodendrocyte injury is an early event in lesions of multiple sclerosis.
@en
Oligodendrocyte injury is an early event in lesions of multiple sclerosis.
@nl
P2093
P1476
Oligodendrocyte injury is an early event in lesions of multiple sclerosis.
@en
P2093
B W Scheithauer
M Rodriguez
P304
P356
10.1016/S0025-6196(12)60597-7
P407
P577
1993-07-01T00:00:00Z